IGM Biosciences, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| IGM Biosciences, Inc. | IGMS - NASDAQ |
$15.00-$17.00 | $16.00 | $18.31 | 10.9 million | 9/18/2019 |
| Jefferies, Piper Jaffray, Stifel, Guggenheim Securities | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-08-19 Terms Added 2019-09-03 Amended Terms 2019-09-17 | ||||||
IGM Biosciences, Inc. Quote & Chart - Click for current quote - IGMS
IPO Boutique aggregates information on public companies and private companies, such as "IGMS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About IGM Biosciences, Inc. (adapted from IGM Biosciences, Inc. prospectus):
They are a biotechnology company pioneering the development of engineered IgM antibodies for the treatment of cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biotechnology company pioneering the development of engineered IgM antibodies for the treatment of cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "IGMS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.